ES2083319A1 - 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)- 6 chloro-1,3-dihydro-2H-indole-2-one hydrochloride monohydrate - Google Patents
5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)- 6 chloro-1,3-dihydro-2H-indole-2-one hydrochloride monohydrateInfo
- Publication number
- ES2083319A1 ES2083319A1 ES09301981A ES9301981A ES2083319A1 ES 2083319 A1 ES2083319 A1 ES 2083319A1 ES 09301981 A ES09301981 A ES 09301981A ES 9301981 A ES9301981 A ES 9301981A ES 2083319 A1 ES2083319 A1 ES 2083319A1
- Authority
- ES
- Spain
- Prior art keywords
- benzisothiazol
- indole
- dihydro
- chloro
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
5-(2-(4-(1,2-benzisothiazol-3-yl)-1- piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indole-2-one hydrochloride monohydrate. 5-(2-(4-(1,2-benzisothiazol-3-yl)- 1piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indole-2-one hydrochloride monohydrate has the advantage of stability for formulation as a neuroleptic agent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9301981A ES2083319B1 (en) | 1993-09-20 | 1993-09-20 | 5- (2- (4- (1,2-BENZISOTIAZOL-3-IL) -1-PIPERAZINYL) -Ethyl) -6-CHLORINE-1,3-DIHYDRO-2H-INDOL-2-ONA MONOHYDRATE. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9301981A ES2083319B1 (en) | 1993-09-20 | 1993-09-20 | 5- (2- (4- (1,2-BENZISOTIAZOL-3-IL) -1-PIPERAZINYL) -Ethyl) -6-CHLORINE-1,3-DIHYDRO-2H-INDOL-2-ONA MONOHYDRATE. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2083319A1 true ES2083319A1 (en) | 1996-04-01 |
ES2083319B1 ES2083319B1 (en) | 1997-01-16 |
Family
ID=8283083
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES9301981A Expired - Fee Related ES2083319B1 (en) | 1993-09-20 | 1993-09-20 | 5- (2- (4- (1,2-BENZISOTIAZOL-3-IL) -1-PIPERAZINYL) -Ethyl) -6-CHLORINE-1,3-DIHYDRO-2H-INDOL-2-ONA MONOHYDRATE. |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2083319B1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0281309A1 (en) * | 1987-03-02 | 1988-09-07 | Pfizer Inc. | Piperazinyl-heterocyclic compounds |
US4831031A (en) * | 1988-01-22 | 1989-05-16 | Pfizer Inc. | Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity |
US4883795A (en) * | 1988-01-22 | 1989-11-28 | Pfizer Inc. | Piperazinyl-heterocyclic compounds |
EP0586191A1 (en) * | 1992-09-01 | 1994-03-09 | Pfizer Inc. | Monohydrate of 5-(2-(4-(1,2 Benzisothiazol-3-YL)-1-Piperazinyl)-Ethyl)-6-Chloro-1,3-Dihydro-2H-indol-2-one Hydrochloride |
-
1993
- 1993-09-20 ES ES9301981A patent/ES2083319B1/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0281309A1 (en) * | 1987-03-02 | 1988-09-07 | Pfizer Inc. | Piperazinyl-heterocyclic compounds |
US4831031A (en) * | 1988-01-22 | 1989-05-16 | Pfizer Inc. | Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity |
US4883795A (en) * | 1988-01-22 | 1989-11-28 | Pfizer Inc. | Piperazinyl-heterocyclic compounds |
EP0586191A1 (en) * | 1992-09-01 | 1994-03-09 | Pfizer Inc. | Monohydrate of 5-(2-(4-(1,2 Benzisothiazol-3-YL)-1-Piperazinyl)-Ethyl)-6-Chloro-1,3-Dihydro-2H-indol-2-one Hydrochloride |
Also Published As
Publication number | Publication date |
---|---|
ES2083319B1 (en) | 1997-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2105114A1 (en) | Monohydrate of 5-(2-(4-(1,2 Benzisothiazol-3-Yl)-1- Piperazinyl)-Ethyl)-6-Chloro-1,3-Dihydro-2H-Indol-2-One Hydrochloride | |
RU93043528A (en) | 5- (2- (4- (1,2-BENZOTIAZOL-3-IL) -1-PIPERAZINYL) Ethyl MONOHYDRATE) -6-CHLOR-1,3-DIHYDRO-2H-INDOL-2-OH CHLOROHYDRATE, METHOD FOR ITS PREPARATION , PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT | |
AP2001002066A0 (en) | Substituted oxazoles and thiazoles derivatives at hPPAR gamma and hPPAR alpha activators | |
AU666413B2 (en) | Antiallergic composition for opthalmic or nasal use | |
TR200000812T2 (en) | 2-methyl-thieno-benzodiazepine formulation. | |
WO2001032652A3 (en) | N-substituted carbamoyloxyalkyl-azolium derivatives | |
WO1999009025A3 (en) | 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor | |
GB9718903D0 (en) | Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents | |
EP0816362A4 (en) | Thiazole derivatives | |
MX9701116A (en) | Pro-drugs of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chl oro-1,3-dihydro-2h-indol-2-one. | |
ES2083319A1 (en) | 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)- 6 chloro-1,3-dihydro-2H-indole-2-one hydrochloride monohydrate | |
CA2244621A1 (en) | 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide y receptor antagonists | |
HU9202914D0 (en) | 4-(4-(4-hydroxiphenyl)-1-piperazinyl)-5-methyl-3h-1,2,4-triazole-3-one derivatives | |
PL348601A1 (en) | New pharmaceutical composition and the process for its preparation | |
MY109504A (en) | Monohydrate of 5-(2-(4-(1,2 benzisothiazol-3-yl)-1- piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2h-indol-2- one hydrochloride | |
CA2423357A1 (en) | Fused heterocyclic derivatives as phosphodiesterase inhibitors | |
ES8504185A1 (en) | Spirothiazolidinyl piperazine derivatives | |
AU779761C (en) | Medicament for treatment of neuropathies | |
GB0021784D0 (en) | Novel pharmaceutical | |
AP1738A (en) | Sodium salts of 5-[4-[2-(N-Methyl -N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione. | |
ES2062940A1 (en) | Gastrokinetic agent, process for its preparation and pharmaceutical compositions containing said agent | |
EP0878475A3 (en) | 5-(4-Piperidinyl)dibenzothiazepine derivatives and 5-(4-piperidinyl)dibenzoxazepine derivatives, and antiarrhythmic agents | |
MY110446A (en) | Piperazine derivatives | |
AU1272701A (en) | Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4- dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate and use thereof as endothelin antagonist | |
HUP9902404A3 (en) | Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-choloro-1,3-dihydro-2(2h)-indol-2-one (-ziprasidone), its preparation and its use as dopamine d2 antagonist |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 19930920 Kind code of ref document: B1 Effective date: 19930920 |
|
FD2A | Announcement of lapse in spain |
Effective date: 20141120 |